NuCana (NCNA) Profit After Tax (2017 - 2025)
NuCana (NCNA) reported Profit After Tax of -$1.3 million for Q3 2025, down 1440589313.39% on a YoY basis from N/an in Q3 2024, and up 96.03% sequentially from -$33.0 million in Q2 2025.
NuCana (NCNA) Profit After Tax (2017 - 2025) Analysis & Trends
NuCana (NCNA) has 9 years of Profit After Tax data on file, last reported at -$1.3 million in Q3 2025.
- For the quarter ending Q3 2025, Profit After Tax fell 1440589313.39% year-over-year to -$1.3 million; the trailing twelve-month figure through Dec 2025 stood at -$38.4 million (down 220.06% YoY), and the FY2024 full-year result was -$0.33, up 100.0% from the prior year.
- Profit After Tax rose to -$1.3 million in Q3 2025, from -$33.0 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of -$0.01 in Q4 2024 to a low of -$33.0 million in Q2 2025.
- A 5-year average of -$10.2 million and a median of -$8.7 million in 2022 frame the typical range for Profit After Tax.
- Across the five-year window, Profit After Tax jumped 100.0% in 2023 and slumped 20138079015.04% in 2025, its largest moves.
- Tracing NCNA's Profit After Tax over 5 years: stood at -$24.0 million in 2021, then advanced by 8.42% to -$22.0 million in 2022, then jumped by 100.0% to -$0.17 in 2023, then surged by 92.61% to -$0.01 in 2024, then plunged by 10208248966.51% to -$1.3 million in 2025.
- Business Quant data shows NCNA's Profit After Tax at -$1.3 million in Q3 2025, -$33.0 million in Q2 2025, and -$4.0 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn | 205.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1.31 Mn |
| Jun 30, 2025 | -33.04 Mn |
| Mar 31, 2025 | -4.00 Mn |
| Dec 31, 2024 | -0.01 |
| Sep 30, 2024 | -0.09 |
| Jun 30, 2024 | -0.16 |
| Mar 31, 2024 | -11.98 Mn |
| Dec 31, 2023 | -0.17 |
| Sep 30, 2023 | -0.16 |
| Jun 30, 2023 | -0.19 |
| Mar 31, 2023 | -11.98 Mn |
| Dec 31, 2022 | -21.96 Mn |
| Sep 30, 2022 | -8.74 Mn |
| Jun 30, 2022 | -7.91 Mn |
| Mar 31, 2022 | -16.73 Mn |
| Dec 31, 2021 | -23.98 Mn |
| Sep 30, 2021 | -16.35 Mn |
| Jun 30, 2021 | -17.13 Mn |
| Mar 31, 2021 | -18.15 Mn |
| Dec 31, 2020 | -20.67 Mn |